## Abstract The original article to which this Erratum refers was published in International Journal of Cancer 2001; 92(6) 856β860.
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
β Scribed by Achim A. Jungbluth; Yao-Tseng Chen; Elisabeth Stockert; Klaus J. Busam; Denise Kolb; Kristin Iversen; Keren Coplan; Barbara Williamson; Nasser Altorki; Lloyd J. Old
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 549 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0020-7136
- DOI
- 10.1002/ijc.1282
No coin nor oath required. For personal study only.
β¦ Synopsis
NY-ESO-1, a member of the CT (cancer/testis) family of antigens, is expressed in normal testis and in a range of human tumor types. Knowledge of NY-ESO-1 expression has depended on RT-PCR detection of mRNA and there is a need for detecting NY-ESO-1 at the protein level. In the present study, a method for the immunochemical detection of NY-ESO-1 in paraffin-embedded tissues has been developed and used to define the expression pattern of NY-ESO-1 in normal tissues and in a panel of human tumors. No normal tissue other than testis showed NY-ESO-1 reactivity, and expression in testis was restricted to germ cells particularly spermatogonia. In human tumors, the frequency of NY-ESO-1 antigen expression corresponds with past analysis of NY-ESO-1 mRNA expression e.g., 20-30% of lung cancers, bladder cancers and melanoma, and no expression in colon and renal cancer. Co-typing of NY-ESO-1 antigen and mRNA expression in a large panel of lung cancers showed a good correlation. There is great variability in NY-ESO-1 expression in individual tumors, ranging from an infrequent homogeneous pattern of staining to highly heterogeneous antigen expression.
π SIMILAR VOLUMES
## Abstract NYβBRβ1 is a differentiation antigen and a potential target for cancer immunotherapy. Its mRNA expression is restricted to breast, testis, prostate and breast cancer by RTβPCR. In this study, we correlated NYβBRβ1 protein and mRNA expression on tissue microarrays of mammary, prostatic a
The expression of growth factors, such as transforming growth factor a (TGFa), amphiregulin (AR) and CRIPTO, a type-I tyrosine-kinase growth factor receptor (erbB-2), and a tumor-suppressor gene (p53). that have been implicated in the development and/or the progression of breast cancer, was evaluate